ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Bl Superstorec1

Bl Superstorec1 (49JE)

0.00
0.00
(0.00%)
Closed December 30 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

49JE News

Official News Only

Discussion

View Full Feed
Eagle1 Eagle1 3 minutes ago
Good Morning All, like this one too RVPH 1.8797 0.0797 (4.43%) 12-30-24
RVPH
GTF GTF 3 minutes ago
This mornings incredible post:
https://x.com/ABIntlGroup/status/1873748749572518301
ABQQ
Magnum7419 Magnum7419 3 minutes ago
wow talk about painting the tape............1 share,sold

nasd
10:05:52 0.0009 1 Sell 0.0009 0.001
AHRO
Wayne R Wayne R 3 minutes ago
Where there is life there is hope
bucks2pennies bucks2pennies 4 minutes ago
No report of O/S increase for some time now. 16.8B+ remains the same as of 12/23/24 per OTC
GTCH
threewheeler threewheeler 4 minutes ago
BOPO tax loss selling some body, and nothing we can do about buying these, talk about sux
BOPO
saj saj 4 minutes ago
Buru nice move today over .7
glenn1919 glenn1919 4 minutes ago
erna.......................https://stockcharts.com/h-sc/ui?s=erna&p=W&b=5&g=0&id=p86431144783
ERNA
jour_trader jour_trader 4 minutes ago
Also, the price will be for 30, 60 or 90 bottles so don't we need to take capsule production max of 57K per 8 hour shift and divide by at least 30? We'd then take this and apply it to about 50% of price we see on GoodRx for a reasonable estimate for Elite revenue after pharmacy, distributor & other
ELTP
prototype_101 prototype_101 4 minutes ago
Hero EXACTLY 💯 in addition to Leonberger buying up 100,000 options outright and disposing ZERO, a couple more things he could consider,

1) the latest round of Annual Incentive Comps were issued at $5 strike, and this was at a time the PPS was in 3's

2) the new C
LWLG
AJH92 AJH92 4 minutes ago
Update - December 30: "United States Citizenship and Immigration Services (USCIS) has released processing data for EB-5 visa petitions through Q4 FY2024. The data includes the filings, approvals, denials, and pending cases of Form I-526 legacy, I-526, and I-526E petition for regional center investor
PSRU
tw0122 tw0122 4 minutes ago
.90s +30%%
JDZG
DaJester DaJester 5 minutes ago
One other thing that I think you are misunderstanding: I think Treasury will end up with 80-99.9% of the final share count, i.e. after considering a junior-to-common conversion and capital raise.

I think this is the fundamental difference in theories. It's going to be exceedingly diff
FNMA
stockprofitter stockprofitter 5 minutes ago
He doesn’t work for the government
FNMA
Wayne R Wayne R 5 minutes ago
You sound like Dylan Hunt

https://g.co/kgs/8k8Q7aj
rosemountbomber rosemountbomber 5 minutes ago
They have been waiting for the new formulation to weave its way through the patent and FDA approval processes.

Do we know if they have actually started the approval process with the FDA? Isn't that material information that they would need to release?

Also, I like the
AMRN
tw0122 tw0122 5 minutes ago
.93
JDZG
dexprs dexprs 5 minutes ago
We may have seen the short term bottom this morning. I am changing my tactics accordingly and will be adding larger positions.
FFFacts FFFacts 5 minutes ago
Why do we only see positive statement gains but never losses from the dishonorably discharged?
FNMA
DewDiligence DewDiligence 5 minutes ago
It’s just under 10% of my overall investment portfolio, but it’s about 30% of the drug/biotech portion of my portfolio.
Trooperstocks Trooperstocks 5 minutes ago
$RELT - The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry. As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its rob
RELT
LowFloatLopes LowFloatLopes 5 minutes ago
Bye bye wall 
HOLO
Trooperstocks Trooperstocks 5 minutes ago
$RELT - The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry. As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its rob
RELT
Omar8 Omar8 6 minutes ago
AlwaysRed,





Dropping to fill those last contracts ?


https://www.cmegroup.com/markets/metals/precious/silver.volume.html
SLV
barttt barttt 6 minutes ago
What is our market cap now?  Seems pretty low for owning a 20mil revenue/year furniture company 
ASKH